Drive graduates pitch investor-ready science as part of a national life sciences accelerator collaboration between SCbio and Massbio
CHARLESTON, SC – May 14, 2026 – SCbio, in collaboration with MassBio, hosted life sciences investors and industry experts for Demo Day on Wednesday to showcase the science of 15 emerging companies and conclude the spring cohort of its national accelerator program, Drive.
After completing the 8-week hybrid program filled with industry-specific curriculum modules led by experts, this cohort of biomarkers and diagnostics companies took the stage to pitch their innovative science to gain the visibility, traction and potential funding needed to propel their startups forward.
The program included a panel discussion featuring Holly Soares, global head of neuroscience and rare disease biomarkers, vice president at Roche, and Matt Clancey, director of new ventures and strategic alliances at Labcorp, focused on practical guidance for early-stage companies positioning themselves for investment and strategic partnerships.
“These biomarkers and diagnostics companies are developing tools to redefine earlier cancer detection, treatment decisions for patients and other vital technologies that can be nurtured by South Carolina’s life sciences resources,” said James Chappell, Ph.D., president and chief executive officer of SCbio. “We want this cohort, and future cohorts, to witness the strength of our biomedical research community, the availability of incubator and lab space, and a culture that values collaboration between startups, universities, and industry.”
This year, SCbio honored two participating companies with Awards of Excellence in recognition of their outstanding pitch presentation and exceptional performance during the accelerator program.
Dxcover received a company presentation session at the 2026 Biocentury Grand Rounds conference, an event that gathers a global network of over 500 decision-makers to learn about business and biopharma research and development opportunities.
General Prognostics received a position as a South Carolina delegate at the 2026 BIO International Convention, the world’s largest industry gathering, bringing together thousands of global biotechnology and biopharmaceutical leaders, where they will make meaningful connections.
The Drive accelerator program selects up to six startups to participate in curriculum modules taught by industry experts at no cost to them. SCbio’s biomarkers and diagnostics cohort curriculum partners include Labcorp, Lilly, K&L Gates, Maynard Nexsen, The Matchstick Group, and VentureSouth, and is supported by premier sponsors Charleston County Economic Development and the South Carolina Department of Commerce.
Since launching in 2022, Drive has supported 59 early-stage companies (70 inclusive of the current cohort) that have raised $290 million in funding.
Applications for the Fall 2026 cohort of Drive will open May 26, 2026.
About SCbio
SCbio is the definitive, unifying leader in South Carolina’s life sciences sector, fostering authentic collaboration and innovation across academia, startups, government and established enterprises. As a member-driven economic development organization, SCbio represents an industry that generates $20.1 billion in annual economic impact and supports 63,000 jobs across South Carolina. Our members are unified by a mission to positively impact humanity through science across the ecosystem of advanced and specialty manufacturing; digital health and the data frontier; and cutting-edge health specializations. For additional information about SCbio and the life sciences industry, or to become a member, visit SCbio.org.
Media Contacts
Connor Watkins
Director of Marketing – SCbio
Cwatkins@scbio.org